53 results about "Immune agent" patented technology

In vivo methods are provided for using an electric field to delivery therapeutic or immunizing treatment to a subject by applying non-invasive, user-friendly electrodes to the surface of the skin. Thus, therapeutic or immunizing agents can be delivered into cells of skin for local and systemic treatments or for immunization with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.

In vivo methods are provided for using an electric field to delivery therapeutic or immunizing treatment to a subject by applying non-invasive, user-friendly electrodes to the surface of the skin. Thus, therapeutic or immunizing agents can be delivered into cells of skin for local and systemic treatments or for immunization with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.

An antiproliferative, antiinflammatory, antiinfective, immunization agent of a metal ion chelating agent such as picolinic acid, analogs or derivatives thereof, and methods of using the same. The agents chelate metals in metal containing protein complexes and enzymes required for growth, replication or inflammatory response. The preparations can be administered systemically or topically. The products can be used to reduce systemic levels of metals in disease states such as Wilson's disease, iron or lead toxicity. The preparations have antineoplastic, antiviral, antiinflammatory, analgesic antiangiogenic and antiproliferative effects and are used in the treatment of warts, psoriasis, acne, cancers, sunburn, inflammatory responses, untoward angiogenesis and other diseases and in the prevention of sexually transmitted diseases such as genital warts, herpes and AIDS.

This invention discloses one EPSPS gene enzyme immune agent case and its use method in the anti-herbicide bean, wherein, the case comprises anti-EPSPS multi-clone antigen, enzyme board with the antigen, enzyme antigens for two, gene switch bean standard product, non-transfer gene bean standard, intense wash liquid, develop liquid and terminal liquid. This invention method comprises the following steps: cloning CP4-EPSPS gene from the gene switch bean expressed in the bacillus coli; then through protein purification complex property to regroup EPSPS protein antibody immune animal to get special single clone antigen and multi-clone antigen; establishing double antigen clamp enzyme immune system test sample to determine its EPSPS protein content.

The invention relates to an enzyme immune agent box for detecting ª‰-excitant drugs, which comprises: enzyme mark plate which coats ª‰-excitant drugs, enzyme mark antibody, clenobuterol standard solution, base material color developing solution, ª‰-excitant drugs antibody working solution, compression cleaning liquid, ending solution and compression twin solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

The invention discloses an enzyme immune agent box for detecting lake drugs of animal foodstuff; it also provides a method for using the agent to detect the lake drugs residue. The agent box comprises: enzyme mark plate which coats lake drugs antigen or antibody, lake drugs mouse monoclonal antibody or polyclonal antibody working solution, enzyme mark antibody or enzyme mark lake drugs antigen, lake drugs standard solution, base material color developing solution, compression cleaning liquid, ending solution and compression twin solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

This invention relates to one anti-extracting nuclear antigen spectrum array to ELISA test agent case for selecting for systematic lupus erythematosus, mixed connective tissue disease, Sjogren syndrome, systemic scleroderma, polymyositis and atrophic arthritis system self immune property antigen ENA spectrum micro array to enzyme immune agent case.

The invention provides an enzyme immune agent box for detecting chloromycetin drugs of animal foodstuff which comprises: enzyme mark plate which coats chloromycetin drugs antigen or antibody, chloromycetin drugs mouse monoclonal antibody compression solution, chloromycetin drugs standard solution, enzyme mark material, base material color developing solution, compression cleaning liquid, ending solution and compression twin solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

The invention provides an enzyme immune agent box for detecting sulpha drugs of animal organization, which uses enzyme immune method to detect the preprocessed animal organization, honey, urine, milk. The enzyme immune agent box comprises: enzyme mark plate which coats sulpha drugs antigen or antibody, sulpha drugs mouse monoclonal antibody working solution, enzyme mark antibody or sulpha drugs antigen solution, sulpha drugs standard solution, base material color developing solution, compression cleaning liquid, ending solution and compression extracting solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

The invention provides an UUV multi-layer hybrid type immune agent structure modeling method. The method comprises the following steps: comparing a biological immune response mechanism and an Agent theory, and proposing an immune agent IA model; abstractly dividing the UUV model into a sensing module, a power propulsion module, a communication module, a control strategy module and a knowledge base module through a building block type modular abstracting method; designing a multi-layer hybrid structural UIA including a sensing performing layer, an action planning layer and a learning and memorizing layer; analyzing the function of each layer; designing formal description for an object; designing an UIA action rule library and a state library in detail; comprehensively describing the properties of an UIA model. According to the method, the UIA structure model built through the method packs a plurality of functions and properties, moreover, the structure layers are clear; the logic is clear; the module division is clear; the UIA structure model is clear to the UUV actual system; the modeling requirement of underwater UAV battle on UUV self-control degree and intelligence level can be achieved.

The invention relates to an enzyme immune agent box for detecting ampicillin G, which comprises: enzyme mark plate which coats ampicillin G antibody or antigen, enzyme mark material, ampicillin G standard solution, base material color developing solution, compression cleaning liquid, ending solution, compression twin solution and antibody working solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

The invention provides an enzyme immune agent box for detecting avermectin drugs which comprises: enzyme mark plate which coats sheep-resistance mouse-resistance antibody, enzyme mark antigen, avermectin drugs antibody, avermectin standard solution, base material color developing solution, compression cleaning liquid, ending solution and compression diluting solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

The invention discloses a method for preparing a controllable highly-efficient microbial culture medium/liquid, which is suitable for the biotechnology industry such as microbial pharmacy and fermentation and other industries which need different microbial culture media/liquids. The controllable highly-efficient microbial culture medium/liquid is characterized in that the culture medium/liquid is dissolved with a dissolved oxygen control agent of fluorocarbon added according to a volume ratio between 1 to 10 and 1 to 10000 and also dissolved with a dissolved oxygen control agent of oxygen, carbon dioxide or helium, wherein the flow of oxygen is 1 to 10 ml/min, the flow of carbon dioxide is 1 to 5 ml/min or the flow of helium is 1 to 5 ml/min flow. The microbial culture medium/liquid can be used for cells amplification, is applicable to the preparation of bacterial immune agents, the beer manufacture, the biological purification and other bioengineering manufacture industries; the fluorocarbon in the microbial culture medium/liquid can be removed by heating or freeze-drying processes.

The invention provides an enzyme immune agent box for detecting atilen residual quantity of animal foodstuff which comprises: enzyme mark plate which coats atilen antigen or antibody, enzyme mark material, atilen peculiar antibody, atilen standard solution, color developing solution, compression cleaning liquid, ending solution and compression twin solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

The invention provides an agent box for detecting fluorine drugs of animal foodstuff, which uses enzyme immune method to detect the preprocessed animal organization, shrimp, fish and blood product. The enzyme immune agent box comprises: enzyme mark plate which coats fluorine drugs antigen, enzyme mark antibody, ciproloxacin standard solution, base material color developing solution, fluorine drugs antibody, compression cleaning liquid, ending solution and compression twin solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

This invention relates to immune group hole dye slice and its usage method, which comprises the following usage steps: sticking tightly more than one transparent holes film slices into load slice coated with organic coupon and dripping immune agent into each hole form immune group dying and the agent volume is limited to the hole edge; ripping off film slices or dipping the load slice into organic liquid to make film peeled off for sealing.

The invention provides an enzyme immune agent box for detecting atilen residual quantity of animal foodstuff which comprises: enzyme mark plate which coats atilen antigen or antibody, enzyme mark material, atilen peculiar antibody, atilen standard solution, color developing solution, compression cleaning liquid, ending solution and compression twin solution. The invention also discloses a method for applying the detecting method, which comprises: first doing sample front process, then using the agent box to detect, at last analyzing the detected result.

Recombinant, attenuated parasites are transformed or transfected with nucleic acid molecules which provoke an immunostimulatory and protective response in subjects. Preferably, the parasite is Trypanosoma cruzi, especially strain CL-14, and the transforming nucleic acid molecule encodes for a cancer testis antigen, such as NY-ESO-1.

The invention provides an egg yolk antibody for preventing and treating vibrio vulnificus infection. The egg yolk antibody is prepared by the following method: (1) separating vibrio vulnificus from asample of a patient infected with the vibrio vulnificus in natural environment; (2) preparing a vibrio vulnificus inactivation somatic antigen, and carrying out immunization on an egg-laying hen; and(3) collecting immunized eggs, and extracting and purifying the egg yolk antibody from the egg yolks of the eggs. The egg yolk antibody disclosed by the invention can effectively neutralize the vibriovulnificus so as to terminate the vibrio vulnificus infection, and an effective passive immune agent for subsequent prevention and control of the vibrio vulnificus is provided.